Talis Biomedical Corp

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$192.2M

94 transactions

Summary

Talis Biomedical Corp is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $106.7MSales: $211K23 insiders

Date	Insider	Type	Value
2024-08-26	Leonard Braden Michael	Buy	$51K
2024-09-06	Leonard Braden Michael	Buy	$37K
2024-09-05	Leonard Braden Michael	Buy	$7K
2024-08-28	Leonard Braden Michael	Buy	$5K
2024-09-03	Leonard Braden Michael	Buy	$2K
2024-08-30	Leonard Braden Michael	Buy	$641.75
2023-08-01	Lukowiak Andrew A(President)	A	$0
2023-07-17	Markovich Rebecca(Interim CFO)	A	$0
2023-06-09	Dreismann Heinrich	A	$0
2023-06-09	Ismagilov Rustem F.	A	$0
2023-06-09	Gilliam Melissa	A	$0
2023-06-09	Popovits Kimberly J	A	$0
2023-06-09	Posard Matthew L.	A	$0
2023-06-09	Scott Randal W.	A	$0
2023-06-09	Joint reporting: BAKER JULIAN; BAKER FELIX; BAKER BROS. ADVISORS LP; Baker Brothers Life Sciences LP; 667, L.P.; Baker Bros. Advisors (GP) LLC	A	$0
2023-06-09	Joint reporting: BAKER JULIAN; BAKER FELIX; BAKER BROS. ADVISORS LP; Baker Brothers Life Sciences LP; 667, L.P.; Baker Bros. Advisors (GP) LLC	A	$0
2023-05-19	Dreismann Heinrich	A	$0
2023-04-07	Kelley Robert J.(Chief Executive Officer)	A	$0
2023-04-07	Moody John Roger Jr(Chief Financial Officer)	A	$0
2022-06-10	Joint reporting: BAKER JULIAN; BAKER FELIX; BAKER BROS. ADVISORS LP; Baker Brothers Life Sciences LP; 667, L.P.; Baker Bros. Advisors (GP) LLC	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Talis Biomedical Corp — Contributions, Lobbying & Contracts | Poliscope